A unit of Fortescue Metals Group has won its bid for emails between Squire Patton Boggs and a unit of electricity provider TransAlta Energy relating to a disputed power purchase agreement, saying privilege was waived when the emails were forwarded to a third party.
Shareholders in a class action against Sirtex have secured an order forcing the life sciences company to notify them of any plan that would see its $128 million in liquid assets drop below $80 million.
HarperCollins has asked the Federal Court to toss a defamation case brought against it by two psychiatrists at the centre of the deep sleep therapy scandal that rocked the medical world in the 1960s and 70s, saying too much time had passed since the scandal.
The former CEO of biotech company Sirtex Medical has been charged with insider trading.
A unit of Rio Tinto has won an appeal allowing it to avoid an $86 million payment owed to failed mining services company Forge Group Power.
A barrister for a group of people set to give evidence against Craig McLachlan at his upcoming defamation trial lost a bid Friday to suppress subpoenas by the actor on the grounds that the definition of ‘sexual harassment’ is too much in “flux”.
A judge in the high-stakes trial over the $420 million sale of Viterra’s Joe White malt business to Cargill has denied Cargill’s request to have settlement talks admitted as evidence, shooting down the agricultural giant’s argument that the talks were needed to challenge Glencore in-house counsel’s assertion that he is of good character and will not breach a confidentiality agreement.
A judge has shot down a last minute bid by an insurance brokerage facing a cross claim in a class action over failed debenture issuer Provident Capital to retract an admission in its defence ahead of trial next month.
Senator David Leyonhjelm wants the Federal Court to toss a defamation lawsuit filed by Senator Sarah Hanson-Young, saying the court is barred from hearing the case due to parliamentary privilege
Shareholders in a class action against Sirtex Medical have lost a bid for an order preventing the life sciences company from quietly moving $128 million in cash assets out of the country after its $1.9 billion takeover by a Chinese private equity company comes into effect Thursday, but the battle over the money will likely continue.